Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Seoul?

Source: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-august-24-30-2026
Scope: Luxury Medical Aesthetic Clinics Seoul · Seoul · AI Overview · Google · Desktop
Family: Ranking Top 10
Observed: August 24–30, 2026 (2026-08-24/2026-08-30)
Published: September 1, 2026
Method — How readings are scoped: https://theobservatory.io/method#standards
Method — Run metadata: https://theobservatory.io/method/panel#run-metadata
Method — Source protocol: https://theobservatory.io/method#source-protocol
Method — Corrections and right of reply: https://theobservatory.io/method#corrections
Public table: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-august-24-30-2026/data.csv
Citation text: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-august-24-30-2026/citation.txt
Reuse terms: https://theobservatory.io/terms

us-uk.bookimed.com holds the strongest AI opening share on this market in this card scope, at 15.03%, across 6 comparable scheduled runs in the observation period August 24–30, 2026.

Key facts:
• us-uk.bookimed.com: 15% AI opening share · opening in 4/6 runs
• reddit.com: 10% AI opening share · opening in 4/6 runs
• seoulcosmeticsurgery.com: 10% AI opening share · opening in 4/6 runs

Published table — AIO opening control — top 10 (August 24–30, 2026 · 80 queries per run · 6 comparable runs): Rank · Actor · AIO opening control
1. us-uk.bookimed.com — 15.03% AI opening share · opening in 4/6 runs — #1
2. reddit.com — 10.46% AI opening share · opening in 4/6 runs — #2
3. seoulcosmeticsurgery.com — 10.46% AI opening share · opening in 4/6 runs — #3
4. youtube.com — 8% AI opening share · opening in 4/6 runs — #4
5. gangnamwomenshealth.com — 7.19% AI opening share · opening in 3/6 runs — #5
6. seoulskinclinicforforeigners.com — 7.19% AI opening share · opening in 3/6 runs — #6
7. creatrip.com — 6.54% AI opening share · opening in 4/6 runs — #7
8. enlienjang.com — 6.54% AI opening share · opening in 4/6 runs — #8
9. noonopiclinic.com — 5.23% AI opening share · opening in 2/6 runs — #9
10. instagram.com — 4.58% AI opening share · opening in 3/6 runs — #10

Reading basis: This card observes the AI Overview opening-control rail for Luxury Medical Aesthetic Clinics Seoul in South Korea on Google desktop, across 6 comparable scheduled runs in the observation period August 24–30, 2026. The panel ranks the top-10 actors by AI opening share on this market, aggregated from 80 observed queries. Per-actor values represent the sum of each actor's AI answer openings across all comparable runs in the period, divided by one single period-wide denominator. AI Overview opening-control evidence was available on 5 of 6 runs. One run on August 26, 2026 returned no AI Overview source competitors; aggregated metric values are computed from the 5 runs with available evidence.

Limitations and non-claims:
— Observes the observed AI answer surface only; within a defined scope and window.
— A period aggregate (6 comparable runs) — not a claim about bookings, revenue, or market share.
— Scoped to Luxury Medical Aesthetic Clinics Seoul Seoul, August 2026; not generalisable beyond this market and window.

— The Observatory · Luxury Medical Aesthetic Clinics Seoul · Seoul · AI Overview · Google · Desktop · August 24–30, 2026
Based on governed AAI Kernel evidence. Capture identifier: pr_1788046639680_kdplal. Cite freely with attribution. Published by The Observatory.
Source footnote: Sourced from a published AAI MIB card. The Observatory publishes this card’s public findings; values are as observed on the search surface, not business-market claims.
Attribution: Published by The Observatory · Based on an AAI Kernel capture · governed by The Observatory editorial system
Cite: According to The Observatory (September 1, 2026), Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Seoul?. https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-august-24-30-2026

This record is the published reading and its public table/slice as served on the card — not the complete underlying capture or provider dataset.
Observed by The Observatory. Not an endorsement, recommendation, market-share claim or commercial ranking.
Free reuse, including commercial republication, under The Observatory’s Terms. Retain attribution, source link, scope and date.
Revision: e721993a6594d092